Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prof Cameron and Best's group in collaboration with Dr Ghevaert have published a paper in Biomaterials showing platelet production from in vitro derived megakaryocytes. Platelet production has always been the bottle neck in the venture to produce platelets for human use in the laboratory. This paper illustrates a very important step to make this a reality and illustrates a brilliant collaboration across disciplines and groups who are part of the BHF Oxbridge Centre of Regenerative Medicine.

The researchers cultured megakaryocytes from induced stem cells on a specialised growth support within a flow chamber that mimics features of the bone marrow. The system is able to produce an out flow of platelets that can take part in clotting. It is hoped that the system will aid in mass production of in vitro platelets and modified platelets as responsive drug delivery devices. The full paper can be found here.

See also

Shepherd et al, Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purity. Biomaterials. 2018.

Moreau et al, Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Comms. 2016.

Similar stories

New target identified to develop treatment for Abdominal Aortic Aneurysm

CRM Publication

A new study from the Smart group has shed light on a key regulatory step in the initiation and progression of Abdominal Aortic Aneurysm by revealing the protective role of a previously little known small protein.

Travels with Vignesh

CRM General

Vignesh Murugesan, a Postdoctoral Researcher in Department of Physiology, Anatomy & Genetics (DPAG), describes how he found his way from the large metropolitan town of Chennai in India to studying regenerative medicine here in Oxford, via an 8 year stint in Sweden.

Genetic breakthrough to target care for deadly heart condition

CRE Research

Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.

Earliest origins of the forming heart identified

CRE Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

CRE Research

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.